- Home
- KROS vs FSBC Comparison
KROS vs FSBC Comparison
Compare KROS & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- FSBC
- Stock Information
- Founded
- KROS 2015
- FSBC 2002
- Country
- KROS United States
- FSBC United States
- Employees
- KROS N/A
- FSBC N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- FSBC Banks
- Sector
- KROS Health Care
- FSBC Finance
- Exchange
- KROS Nasdaq
- FSBC Nasdaq
- Market Cap
- KROS 565.0M
- FSBC 628.9M
- IPO Year
- KROS 2020
- FSBC 2021
- Fundamental
- Price
- KROS $16.04
- FSBC $33.75
- Analyst Decision
- KROS Buy
- FSBC Buy
- Analyst Count
- KROS 14
- FSBC 5
- Target Price
- KROS $20.56
- FSBC $34.80
- AVG Volume (30 Days)
- KROS 383.7K
- FSBC 28.8K
- Earning Date
- KROS 11-05-2025
- FSBC 10-27-2025
- Dividend Yield
- KROS N/A
- FSBC 2.38%
- EPS Growth
- KROS N/A
- FSBC 2.40
- EPS
- KROS 0.47
- FSBC 2.44
- Revenue
- KROS $232,844,000.00
- FSBC $132,133,000.00
- Revenue This Year
- KROS $5,998.31
- FSBC $31.83
- Revenue Next Year
- KROS N/A
- FSBC $15.58
- P/E Ratio
- KROS $34.39
- FSBC $13.78
- Revenue Growth
- KROS 85820.30
- FSBC 18.01
- 52 Week Low
- KROS $9.12
- FSBC $22.22
- 52 Week High
- KROS $72.37
- FSBC $35.13
- Technical
- Relative Strength Index (RSI)
- KROS 62.64
- FSBC 65.92
- Support Level
- KROS $15.34
- FSBC $31.90
- Resistance Level
- KROS $16.11
- FSBC $33.88
- Average True Range (ATR)
- KROS 0.44
- FSBC 0.82
- MACD
- KROS -0.01
- FSBC -0.04
- Stochastic Oscillator
- KROS 94.25
- FSBC 93.43
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.